What Changed
Price Move History
- Daily moves over 5%
- 27 196 sessions, February 6, 2026 to November 16, 2026
- Largest daily move
- +15% close of April 13, 2026
- 1-month change
- +34.3% closing prices, October 16, 2026 to November 16, 2026
Company Description
SpyGlass Pharma (NASDAQ: SGP) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.1B.
SGP has gained 34.3% over the past month. The last closing price was $32.24.
For FY2025, SpyGlass Pharma reported net income of -$39.9M and diluted earnings per share of -$17.98.
This page collects what Stock Titan holds for SGP, including price data, latest news, SEC filings, financial highlights, upcoming events, and short interest trends.
Stock Performance
SpyGlass Pharma (SGP) closed at $32.24 on November 16, 2026. Over the past month, the price has gained 34.3%.
SGP Metrics & Rankings
Price returns through November 16, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
SpyGlass Pharma has 10 recent news articles, with the latest published 5 days ago. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, conferences, acquisition. View all SGP news →
SEC Filings
SpyGlass Pharma has filed 10 recent SEC filings, including 6 Form 8-K, 3 Form 10-Q, 1 Form 10-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SGP SEC filings →
Financial Highlights
SpyGlass Pharma reported operating income of -$41.4M in FY2025, and net income was -$39.9M. Diluted earnings per share stood at -$17.98. The company generated -$32.7M in operating cash flow. The current ratio was 12.67, measuring current assets divided by current liabilities.
Upcoming Events
Jefferies fireside chat
Citi fireside chat
Phase 3 enrollment completion
SpyGlass Pharma has 3 upcoming scheduled events. The next event, "Jefferies fireside chat", is scheduled for November 17, 2026 (tomorrow). Investors can track these dates to stay informed about potential catalysts that may affect the SGP stock price.
Short Interest History
Short interest in SpyGlass Pharma (SGP) currently stands at 1.2 million shares, down 5.2% from the previous reporting period, representing 3.6% of the float. Since February 2026, short interest has increased by 541.0%.
Days to Cover History
Days to cover for SpyGlass Pharma (SGP) currently stands at 12.1 days, down 23% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since February 2026, the figure has increased by 1005.5%. Across the settlements charted above, it has ranged from 1.1 to 19.4 days.
SGP Company Profile & Sector Positioning
SpyGlass Pharma (SGP) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing SGP often look at related companies in the same sector, including Mentari Therapeutics, Inc. (MTRI), Seaport Therapeutics, Inc. (SPTX), MoonLake Immunotherapeutics (MLTX), Vor Biopharma Inc. (VOR), and Alto Neuroscience Inc. (ANRO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SGP's relative position within its industry.